LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 2 | O02 | 72 | hr | 1401 | 1250 | 4223 | 0.2960 | -0.0537 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 3 | O02 | 72 | hr | 1401 | 1301 | 4223 | 0.3081 | -0.0356 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 1 | O02 | 72 | hr | 1401 | 1109 | 4223 | 0.2626 | -0.1037 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 2 | O02 | 72 | hr | 1401 | 1323 | 4223 | 0.3133 | -0.0278 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 3 | O02 | 72 | hr | 1401 | 1137 | 4223 | 0.2692 | -0.0938 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1401 | 458 | 4223 | 0.1085 | -0.3344 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1401 | 1272 | 4223 | 0.3012 | -0.0459 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1401 | 1255 | 4223 | 0.2972 | -0.0519 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 1401 | 803 | 4223 | 0.1902 | -0.2121 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1401 | 1101 | 4223 | 0.2607 | -0.1065 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1401 | 966 | 4223 | 0.2287 | -0.1544 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1401 | 4212 | 4223 | 0.9974 | 0.9961 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1401 | 4184 | 4223 | 0.9907 | 0.9862 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1401 | 4361 | 4223 | 1.0327 | 1.0489 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1401 | 807 | 4223 | 0.1911 | -0.2107 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1401 | 916 | 4223 | 0.2169 | -0.1721 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1401 | 1049 | 4223 | 0.2484 | -0.1249 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 1 | F20 | 72 | hr | 1401 | 2972 | 4223 | 0.7038 | 0.5566 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 2 | F20 | 72 | hr | 1401 | 2977 | 4223 | 0.7049 | 0.5584 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 3 | F20 | 72 | hr | 1401 | 3292 | 4223 | 0.7795 | 0.6700 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 1 | B14 | 72 | hr | 1401 | 1268 | 4223 | 0.3003 | -0.0473 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 2 | B14 | 72 | hr | 1401 | 1105 | 4223 | 0.2617 | -0.1051 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 3 | B14 | 72 | hr | 1401 | 1339 | 4223 | 0.3171 | -0.0222 |
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 1 | B08 | 72 | hr | 1401 | 1257 | 4223 | 0.2977 | -0.0512 |
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 2 | B08 | 72 | hr | 1401 | 1236 | 4223 | 0.2927 | -0.0587 |